Dr Frances Hall studied Medicine and later gained a DPhil at Oxford University. She gained further research experience as a postdoctoral fellow in California in 1997-2000.

Her clinical training in Rheumatology took place in Cambridge (SHO), at the Hammersmith Hospital (Registrar) and in Oxford (Clinician Scientist). 

Dr Hall was appointed as a Lecturer in Rheumatology and Honorary Consultant at Addenbrooke’s Hospital in Cambridge in 2003 and she was appointed to a substantive NHS Consultant post in 2012.

Dr Hall established the Connective Tissue Disease clinic at Addenbrooke’s Hospital in Cambridge.

She is the Chair of the Eastern Network for Rare Autoimmune Disease Chair the East Anglian Rheumatology Society (2019-2021) and represents Midlands and East on the Specialised Rheumatology Clinical Reference Group 2016-21. 

Publications, Links, and Resources

Coath F, Gillbert K, Griffiths B, Hall F, Kay L, Lanyon P, Luqmani R, Mackie SL, Mason JC, Mills J, Mollan S, Morgan AW, Mukhtyar C, Quick V, Watts R, Dasgupta B
Giant cell arteritis: new concepts, treatments and the unmet need that remains
Rheumatology (Oxford). 2019 Jul 1;58(7):1316. doi: 10.1093/rheumatology/key411
Cassia MA, Alberici F, Jones RB, Smith RM, Casazza G, Urban ML, Emmi G, Moroni G, Sinico RA, Messa P, Hall F, Vaglio A, Gallieni M, Jayne DR.
Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients.
Arthritis Rheumatol.  2019 Oct;71(10):1670-1680. doi: 10.1002/art.40932.
 
Htut E, Hall F
Vaccination in SLE patients.
Lupus. 2018 Oct;27(1_suppl):36-39. doi: 10.1177/0961203318801697.
 
Wilkinson JD, Leggett SA, Marjanovic EJ, Moore TL, Allen J, Anderson ME, Britton J, Buch MH, Del Galdo F, Denton CP, Dinsdale G, Griffiths B, Hall F, Howell K, MacDonald A, McHugh NJ, Manning JB, Pauling JD, Roberts C, Shipley JA, Herrick AL, Murray AK.
A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon.
Arthritis Rheumatol. 2018 Jun;70(6):903-911. doi: 10.1002/art.40457.
 
Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.
Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.
 
Fisher BA, Everett CC, Rout J, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Carr A, Pease CT, Price EJ, Sutcliffe N, Makdissi J, Tappuni AR, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Richards A, Sharples LD, Bombardieri M, Bowman SJ.
Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy.
Ann Rheum Dis. 2018 Mar;77(3):412-416. doi: 10.1136/annrheumdis-2017-212268. Epub 2017 Dec 23.
 
Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.
Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.
 
Bowman SJ, Everett CC, O'Dwyer JL, Emery P, Pitzalis C, Ng WF, Pease CT, Price EJ, Sutcliffe N, Gendi NST, Hall FC, Ruddock SP, Fernandez C, Reynolds C, Hulme CT, Davies KA, Edwards CJ, Lanyon PC, Moots RJ, Roussou E, Giles IP, Sharples LD, Bombardieri M.
Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.
Arthritis Rheumatol. 2017 Jul;69(7):1440-1450. doi: 10.1002/art.40093. Epub 2017 Jun 5.
 
Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.
 
Mäki-Petäjä KM, Day L, Cheriyan J, Hall FC, Östör AJ, Shenker N, Wilkinson IB.
Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.
J Am Heart Assoc. 2016 Feb 19;5(2). pii: e002762. doi: 10.1161/JAHA.115.002762.
PMID: 26896473
 
Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL.
Consensus best practice pathway of the UK Systemic Sclerosis Study Group: digital vasculopathy in systemic sclerosis.
Rheumatology (Oxford). 2015. 54(11):2015-24. doi: 10.1093/rheumatology/kev201
 
Nikiphorou E, Hall FC.
First report of improvement of coeliac disease in a patient with Sjogren’s syndrome treated with rituximab. Rheumatology (Oxford). 2014. 53(10): 1906-7
 
Saketkoo LA, Mittoo S, Huscher D, Khanna D, Dellaripa PF, Distler O, Flaherty KR, Frankel S, Oddis CV, Denton CP, Fischer A, Kowal-Bielecka OM, LeSage D, Merkel PA, Phillips K, Pittrow D, Swigris J, Antoniou K, Baughman RP, Castelino FV, Christmann RB, Christopher-Stine L, Collard HR, Cottin V, Danoff S, Highland KB, Hummers L, Shah AA, Kim DS, Lynch DA, Miller FW, Proudman SM, Richeldi L, Ryu JH, Sandorfi N, Sarver C, Wells AU, Strand V, Matteson EL, Brown KK, Seibold JR; CTD-ILD Special Interest Group.
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
Thorax. 2014 May;69(5):428-36 (FC Hall coauthor within Special Interest Group).
 
Hadjinicolaou AV, Wu L, Fang B, Watson PA, Hall FC, Busch R.
Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases. Clin Exp Immunol. 2013 Oct;174(1):73-88.
 
Mäki-Petäjä KM, Elkhawad M, Cheriyan J, Joshi FR, Ostör AJ, Hall FC, Rudd JH, Wilkinson IB.
Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis.
Circulation. 2012 Nov 20;126:2473-80
 
Malaviya AP, Hall FC.
Targeting CVD risk in chronic connective tissue disease.
Practitioner. 2012, 256: 21-6
 
Busch R, Hadjinicolaou AV, Hall FC.
Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren's Syndrome.
Curr Pharm Biotechnol. 2012, 13: 2009-21
 
Fang B, Bhagat S, Busch R, Parfrey H, Hall F.
Potential Biomarkers of Monocyte/Macrophage Activity in a Patient with Sarcoidosis, Treated with Infliximab. Rheumatology 2011: 50: 992-4; doi:10.1093/rheumatology/keq449
 
Mäki-Petäjä KM, Cheriyan J, Booth AD, Hall FC, Brown J, Wallace SM, Ashby MJ, McEniery CM, Wilkinson IB.
Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol. 2008; 129: 399-405

Teir J, Koduri G, Meadows A, Griffin J, Kelsey C, Kola A, Persey M, Sinclair H, Yuksel F, Moshtaghi P, Ramabhadram B, Poole K, Pradeep J, Lane S, Pountain G, Scott DGI, Sheehan NJ, Stodell M, Young A, Hall FC. An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in centres in East Anglia and the South East. Rheumatology 2008; 47: 1252-4

Maki Petaja KM, Booth AD, Hall FC, Wallace SM, Furlong A, Cheriyan J, Ashby MJ, McEniery CM, Brown J, Wilkinson IB. Ezetimibe and simvastatin reduce inflammation, disease activity, aortic stiffness and improve endothelial function in rheumatoid arthritis. J Am Coll Cardol; 2007 50:852-858

Maki-Petaja K, Hall FC, Booth AD, Wallace SML, Yasmin, Bearcroft WP, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB.
Rheumatoid arthritis is associated with increased aortic pulse wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006 114: 1185-92

Hall FC and Dalbeth N
Disease modification and cardiovascular risk reduction: two sides of the same coin? Rheumatology 2005 44: 1473-82

Loughry A., Fairchild, S., Athanasou, N., Edwards, J., Hall, F.C.
Inflammatory arthritis and dermatitis in thymectomized, CD25+ cell-depleted adult mice. Rheumatology 2005 44: 299-308.

Dalbeth N, Edwards J, Fairchild S, Callan M, Hall F
The non-thiol angiotensin-converting enzyme inhibitor quinapril suppresses inflammatory arthritis. Rheumatology 2005 44: 24-31

Hall FC, Rabinowitz JD, Busch R, Visconti KC, Belmares M, Patil NS, Cope AP, Patel S, McConnell HM, Mellins ED, Sonderstrup G. 2002
Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes . Eur J Immunol 32:662-70